Skip to main content
Caplight Logo









Sarcura

Sarcura

Private
KlosterneuburgHealthcare & Life Scienceshttps://sarcura.com

Last Round

Grant

Mar 5, 2024

Total Funding Raised

$13.92M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Sarcura is a biotech company that develops a machine platform for the large-scale, industrial manufacturing of personalized cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

cell therapy manufacturingmicrofluidicsbiomanufacturingCAR-Tlab-on-a-chipbioprocessingautomated cell therapysilicon photonicsCDMOcontract development and manufacturing organizationsingle-use technologypersonalized medicinebiotech equipmentPATprocess analytical technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sarcura Comparables

Compare Sarcura with similar companies based on industry and business-model similarity.

Sarcura comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Astraveus
89%
Limula
88%
MFX
81%

Sarcura Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 5, 2024
GrantJun 1, 2023
SeedNov 17, 2022
GrantMar 1, 2021
SeedNov 19, 2020

Key People

Founding team and executive leadership

Erwin Gorjup

Chief Scientific Officer & Co-Founder

Founding Team

Daniela Buchmayr

CEO Co-Founder

Founding Team

Sarcura Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 367% MoM, from 116 to 542.

  • Jan 1, 2025

    Won the LLB Banking Österreich zukunft award 2025.

Sarcura Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sarcura Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sarcura's valuation, stock price, and market status.

Firmographic Details

HeadquartersKlosterneuburg
Employee Range10
Year Founded2019
Last FundingMar 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?